By MedPage Today | February 10, 2015
When the FDA found violations of safety or quality standards at clinical trial sites, the published peer-reviewed reports on these studies rarely mentioned the problems, according to journalism professor Charles Seife, MS, of New York University.
Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...
Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...
